Matches in SemOpenAlex for { <https://semopenalex.org/work/W2321393770> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2321393770 endingPage "A437" @default.
- W2321393770 startingPage "A436" @default.
- W2321393770 abstract "In March, the National Institute for Health and Care Excellence (NICE) revealed their plans to implement Value Based Assessment (VBA) in their Technology Appraisal process: VBA will replace NICE’s end-of-life criteria. Instead wider societal impact (WSI) and burden of illness (BOI) will be systematically included in the assessment through absolute and proportional Quality Adjusted Life Year (QALY) shortfall. However, it is unclear whether these elements will impact NICE’s recommendations. The BOI and WSI for the 26 examples provided by NICE was compared with an average displaced treatment in the NHS. Assuming that both elements were weighted equally, an average QALY shortfall rating was calculated. This was then transformed into a hypothetical willingness to pay (WTP) threshold ranging from £20,000 for the drug with the lowest rating to £50,000 per QALY for the drug with the highest rating. The hypothetical WTP was compared with the most plausible ICER and recommendation from NICE. Multiple Sclerosis, rheumatoid and psoriatic arthritis, as well as oncology indications were associated with a high BOI/WSI. Six of the 26 examples had higher most plausible ICERs than the estimated threshold. Two of these six were still recommended using end-of-life criteria (metastatic melanoma and mCRPC), whereas the remainder were not recommended by NICE. Three of the 26 examples had ICERs below the estimated WTP threshold but higher than £30,000, and were still recommended. All of these recommendations mentioned additional value elements such as innovation, end-of-life criteria or even QoL impact on family. This analysis presented a possible scenario for the implementation of VBA. None of the drugs with a negative recommendation would get a positive recommendation under this scenario. The products at most risk are those currently accepted using end-of-life criteria. However, how the new value elements will be weighted has yet to be determined." @default.
- W2321393770 created "2016-06-24" @default.
- W2321393770 creator A5048094802 @default.
- W2321393770 creator A5056164853 @default.
- W2321393770 creator A5068175028 @default.
- W2321393770 date "2014-11-01" @default.
- W2321393770 modified "2023-09-26" @default.
- W2321393770 title "Will Value Based Assessment (VBA) Revolutionise The Nice Assessment?" @default.
- W2321393770 doi "https://doi.org/10.1016/j.jval.2014.08.1130" @default.
- W2321393770 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27201156" @default.
- W2321393770 hasPublicationYear "2014" @default.
- W2321393770 type Work @default.
- W2321393770 sameAs 2321393770 @default.
- W2321393770 citedByCount "0" @default.
- W2321393770 crossrefType "journal-article" @default.
- W2321393770 hasAuthorship W2321393770A5048094802 @default.
- W2321393770 hasAuthorship W2321393770A5056164853 @default.
- W2321393770 hasAuthorship W2321393770A5068175028 @default.
- W2321393770 hasBestOaLocation W23213937701 @default.
- W2321393770 hasConcept C105795698 @default.
- W2321393770 hasConcept C112930515 @default.
- W2321393770 hasConcept C162118730 @default.
- W2321393770 hasConcept C162324750 @default.
- W2321393770 hasConcept C175444787 @default.
- W2321393770 hasConcept C17744445 @default.
- W2321393770 hasConcept C199360897 @default.
- W2321393770 hasConcept C199539241 @default.
- W2321393770 hasConcept C2776291640 @default.
- W2321393770 hasConcept C2777352838 @default.
- W2321393770 hasConcept C2777364431 @default.
- W2321393770 hasConcept C2779256446 @default.
- W2321393770 hasConcept C3019080777 @default.
- W2321393770 hasConcept C33923547 @default.
- W2321393770 hasConcept C41008148 @default.
- W2321393770 hasConcept C64332521 @default.
- W2321393770 hasConcept C71924100 @default.
- W2321393770 hasConceptScore W2321393770C105795698 @default.
- W2321393770 hasConceptScore W2321393770C112930515 @default.
- W2321393770 hasConceptScore W2321393770C162118730 @default.
- W2321393770 hasConceptScore W2321393770C162324750 @default.
- W2321393770 hasConceptScore W2321393770C175444787 @default.
- W2321393770 hasConceptScore W2321393770C17744445 @default.
- W2321393770 hasConceptScore W2321393770C199360897 @default.
- W2321393770 hasConceptScore W2321393770C199539241 @default.
- W2321393770 hasConceptScore W2321393770C2776291640 @default.
- W2321393770 hasConceptScore W2321393770C2777352838 @default.
- W2321393770 hasConceptScore W2321393770C2777364431 @default.
- W2321393770 hasConceptScore W2321393770C2779256446 @default.
- W2321393770 hasConceptScore W2321393770C3019080777 @default.
- W2321393770 hasConceptScore W2321393770C33923547 @default.
- W2321393770 hasConceptScore W2321393770C41008148 @default.
- W2321393770 hasConceptScore W2321393770C64332521 @default.
- W2321393770 hasConceptScore W2321393770C71924100 @default.
- W2321393770 hasIssue "7" @default.
- W2321393770 hasLocation W23213937701 @default.
- W2321393770 hasLocation W23213937702 @default.
- W2321393770 hasOpenAccess W2321393770 @default.
- W2321393770 hasPrimaryLocation W23213937701 @default.
- W2321393770 hasRelatedWork W1984735078 @default.
- W2321393770 hasRelatedWork W2031176180 @default.
- W2321393770 hasRelatedWork W2055952262 @default.
- W2321393770 hasRelatedWork W2078101009 @default.
- W2321393770 hasRelatedWork W2129750793 @default.
- W2321393770 hasRelatedWork W2133191722 @default.
- W2321393770 hasRelatedWork W2168886263 @default.
- W2321393770 hasRelatedWork W2331082360 @default.
- W2321393770 hasRelatedWork W2942977096 @default.
- W2321393770 hasRelatedWork W4311339034 @default.
- W2321393770 hasVolume "17" @default.
- W2321393770 isParatext "false" @default.
- W2321393770 isRetracted "false" @default.
- W2321393770 magId "2321393770" @default.
- W2321393770 workType "article" @default.